Cheuk Hong Leung

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 604 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Immuno-genomic landscape of osteosarcoma

Chia-Chin Wu, Hannah C. Beird, J. Andrew Livingston et al. · Nature Communications · 2020 · 244 citations · Full text

Medicine, Immunology, Oncology +17

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study.

Tina Cascone, William Nassib William, Annikka Weissferdt et al. · Journal of Clinical Oncology · 2019 · 145 citations

Medicine, Immunology, Oncology +17

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Tina Cascone, Annikka Weissferdt, Myrna C. B. Godoy et al. · Nature Communications · 2021 · 107 citations · Full text

Medicine, Immunology, Oncology +17